Fabian D Mairinger
Overview
Explore the profile of Fabian D Mairinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mathilakathu A, Borchert S, Wessolly M, Mairinger E, Beckert H, Steinborn J, et al.
Transl Lung Cancer Res
. 2021 Aug;
10(7):3030-3042.
PMID: 34430345
Background: Malignant pleural mesothelioma (MPM) is a rare malignant tumor associated with asbestos exposure, with infaust prognosis and overall survival below 20 months in treated patients. Platinum is still the...
12.
Gregorius J, Wang C, Stambouli O, Hussner T, Qi Y, Tertel T, et al.
Basic Res Cardiol
. 2021 Jun;
116(1):40.
PMID: 34105014
Obtained from the right cell-type, mesenchymal stromal cell (MSC)-derived small extracellular vesicles (sEVs) promote stroke recovery. Within this process, microvascular remodeling plays a central role. Herein, we evaluated the effects...
13.
Brcic L, Mathilakathu A, Walter R, Wessolly M, Mairinger E, Beckert H, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33917061
Malignant pleural mesothelioma (MPM) is an aggressive malignancy associated with asbestos exposure. Median survival ranges from 14 to 20 months after initial diagnosis. As of November 2020, the FDA approved...
14.
Borchert S, Suckrau P, Walter R, Wessolly M, Mairinger E, Steinborn J, et al.
Sci Rep
. 2020 Oct;
10(1):18677.
PMID: 33122816
Malignant pleural mesothelioma (MPM) is a rare, but aggressive tumor with dismal prognosis. Platinum-based chemotherapy is regularly used as part of multimodality therapy. The expression of metallothioneins (MT) has been...
15.
Wessolly M, Stephan-Falkenau S, Streubel A, Werner R, Borchert S, Griff S, et al.
Cancer Manag Res
. 2020 Sep;
12:7881-7890.
PMID: 32922086
Background: Immune checkpoint inhibition, especially the blockade of PD-1 and PD-L1, has become one of the most thriving therapeutic approaches in modern oncology. Immune evasion caused by altered tumor epitope...
16.
Borchert S, Suckrau P, Wessolly M, Mairinger E, Hegedus B, Hager T, et al.
J Oncol
. 2020 Jan;
2019:2902985.
PMID: 31929796
Background: Malignant pleural mesothelioma (MPM) is a rare, predominantly asbestos-related and biologically highly aggressive tumor associated with a dismal prognosis. Multimodal therapy consisting of platinum-based chemotherapy is the treatment of...
17.
Konig L, Mairinger F, Hoffmann O, Bittner A, Schmid K, Kimmig R, et al.
BMC Cancer
. 2019 Feb;
19(1):120.
PMID: 30717704
Background: Tumor-infiltrating lymphocytes (TILs) are described as an important immune modulator in the tumor microenvironment and are associated with breast cancer (BC) outcome. The spatial analysis of TILs and TIL...
18.
Borchert S, Wessolly M, Schmeller J, Mairinger E, Kollmeier J, Hager T, et al.
BMC Cancer
. 2019 Feb;
19(1):108.
PMID: 30700254
Background: Malignant pleural mesothelioma (MPM) is a tumour arising from pleural cavities with poor prognosis. Multimodality treatment with pemetrexed combined with cisplatin shows unsatisfying response-rates of 40%. The reasons for...
19.
Schmeller J, Wessolly M, Mairinger E, Borchert S, Hager T, Mairinger T, et al.
Pathol Res Pract
. 2019 Jan;
215(2):381-386.
PMID: 30606660
Introduction: The usage of formalin-fixed paraffin embedded (FFPE) tissue is characterized by its long shelf-life and simple handling. Therefore it is the most commonly available tissue specimen in routine diagnostics...
20.
Walter R, Werner R, Wessolly M, Mairinger E, Borchert S, Schmeller J, et al.
J Oncol
. 2018 Aug;
2018:1986982.
PMID: 30112000
Previously, our group demonstrated that nuclear expression of E3 ubiquitin ligase (MDM2) in malignant pleural mesothelioma (MPM) is significantly associated with decreased overall survival. A possible explanation may be that...